Initial regimensAlternative regimensPregnancyRecurrenceTreatment of sex partners
Bacterial vaginosis
Metronidazole (Flagyl), 500 mg orally twice daily for seven days*
or
Metronidazole 0.75% gel (Metrogel), one full applicator (5 g) intravaginally daily for five days
or
Clindamycin 2% cream, one full applicator (5 g) intravaginally at bedtime for seven days
Tinidazole (Tindamax), 2 g orally once daily for two days
or
Tinidazole, 1 g orally once daily for five days
or
Clindamycin, 300 mg orally twice daily for seven days
or
Clindamycin (Cleocin Ovules), 100 mg intra-vaginally at bedtime for three days
Metronidazole, 500 mg orally twice daily for seven daysFirst recurrence:
  • Retrial of same regimen

    or

    Trial of alternative initial regimen


  • Multiple recurrences:

  • Metronidazole 0.75% gel, intravaginally twice weekly for four to six months

Routine treatment of sex partners is not recommended
Vulvovaginal candidiasis
Topical azole therapy (Table 5)
or
Fluconazole (Diflucan), 150 mg orally, single dose
Topical azole therapy applied intravaginally for seven daysTo achieve mycologic cure§:
  • Topical azole therapy for seven to 14 days

    or

    Fluconazole, 150 mg orally every third day for three doses


  • For maintenance:

  • Oral fluconazole (100 mg, 150 mg, or 200 mg) weekly for six months; consider topical treatment if oral is not feasible

Routine treatment of sex partners is not recommended unless the partner is symptomatic
Trichomoniasis
Metronidazole, 2 g orally, single or divided dose on the same day
or
Tinidazole, 2 g orally, single dose
Metronidazole, 500 mg orally twice daily for seven daysMetronidazole, 2 g orally, single dose in any stage of pregnancyDifferentiate persistent or recurrent infection from reinfection
If metronidazole, 2-g single dose fails:
  • Trial of metronidazole, 500 mg twice daily for seven days


If metronidazole, 500 mg twice daily for seven days fails:
  • Trial of metronidazole, 2 g daily for seven days


If above regimens fail:
  • Consider susceptibility testing (contact Centers for Disease Control and Prevention)

Concurrent treatment of sex partners is recommended
Advise refraining from intercourse until partners are treated and symptom-free